CVS HEALTH CORPORATION CVS

$94.99 +0.29% at last close

Recent SEC Filings

FormDescriptionFiledDocument
13F-HR Institutional holdings 2026-08-06 View →
10-Q 10-Q 2026-08-05 View →
8-K 8-K 2026-08-05 View →
4 PRIMARY DOCUMENT 2026-06-29 View →
4 PRIMARY DOCUMENT 2026-06-01 View →
4 PRIMARY DOCUMENT 2026-06-01 View →
4 PRIMARY DOCUMENT 2026-05-22 View →
4 Insider transaction 2026-05-21 View →
8-K 8-K 2026-05-18 View →
4 PRIMARY DOCUMENT 2026-05-15 View →
4 PRIMARY DOCUMENT 2026-05-15 View →
4 PRIMARY DOCUMENT 2026-05-15 View →
4 PRIMARY DOCUMENT 2026-05-15 View →
4 PRIMARY DOCUMENT 2026-05-15 View →
4 PRIMARY DOCUMENT 2026-05-15 View →
4 PRIMARY DOCUMENT 2026-05-15 View →
4 PRIMARY DOCUMENT 2026-05-15 View →
4 PRIMARY DOCUMENT 2026-05-15 View →
4 PRIMARY DOCUMENT 2026-05-15 View →
4 PRIMARY DOCUMENT 2026-05-15 View →
4 PRIMARY DOCUMENT 2026-05-15 View →
4 PRIMARY DOCUMENT 2026-05-11 View →
13F-HR Institutional holdings 2026-05-07 View →
10-Q 10-Q 2026-05-06 View →
8-K 8-K 2026-05-06 View →
DEF 14A DEFINITIVE PROXY STATEMENT 2026-04-03 View →
4 PRIMARY DOCUMENT 2026-04-02 View →
4 PRIMARY DOCUMENT 2026-04-02 View →
4 PRIMARY DOCUMENT 2026-04-02 View →
4 PRIMARY DOCUMENT 2026-04-02 View →
4 PRIMARY DOCUMENT 2026-04-02 View →
4 PRIMARY DOCUMENT 2026-04-02 View →
4 PRIMARY DOCUMENT 2026-04-02 View →
4 PRIMARY DOCUMENT 2026-04-02 View →
4 PRIMARY DOCUMENT 2026-04-02 View →
4 PRIMARY DOCUMENT 2026-03-20 View →
8-K 8-K 2026-03-19 View →
4 PRIMARY DOCUMENT 2026-03-02 View →
4 PRIMARY DOCUMENT 2026-03-02 View →
13F-HR Institutional holdings 2026-02-13 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$94.99
Market Cap
$121.14 billion
52-Week Range
$58.50 $110.68
Average Volume
8.04 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.